跳至主要内容
临床试验/CTRI/2019/06/019598
CTRI/2019/06/019598已完成4 期

A PROSPECTIVE, RANDOMIZED, OPEN LABEL STUDY TO ASSESS THE ROLE OF VITAMIN C AS AN ADJUVANT TO PAROXETINE IN PHARMACOTHERAPY OF MAJOR DEPRESSIVE DISORDER

Dr Kohima Aggarwal0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Diagnosed cases of major depressive disorder according to ICD-10 visiting psychiatry OPD.
  • 2.Both male and female patients between the ages of 18-65 years.
  • 3.Patients willing to join the study after giving the informed consent

排除标准

  • 1.Patient not willing to give consent for the study.
  • 2.Patients with any organic cause of depression.
  • 3.Any major comorbidities like cardiovascular, renal and hepatic diseases.
  • 4.Any other psychiatric comorbidities.
  • 5.Special physiological conditions like pregnancy, and lactation.
  • 6.Patients using drugs that may interact with Vitamin C like-bishydroxycoumarin and with Proxetine like- thioridazine, pimozide, tamoxifen, warfarin, NSAIDs, alcohol, tryptophan, monoamine oxidase inhibitors like- linezolid and intravenous methylene blue, triptans, lithium, fentanyl, tramadol, cimetidine, other SSRIs and SNRIs, phenobarbital, phenytoin, imipramine, risperidone and any other potential drug interaction.

研究者

发起方
Dr Kohima Aggarwal

相似试验

已完成
4 期
A PROSPECTIVE, RANDOMIZED AND OPEN LABEL STUDY TO COMPARE EFFICACY AND SAFETY OF TOPICAL GLUTATHIONE (2%) WITH TOPICAL TRANEXAMIC ACID (3%) IN ADULT MELASMA PATIENTSMELASMA
JPRN-UMIN000050940DEPARTMENT OF PHARMACOLOGY, GOVERNMENT MEDICAL COLLEGE AMRITSAR60
进行中(未招募)
不适用
AN OPEN-LABEL; RANDOMIZED; PROSPECTIVE STUDY TO INVESTIGATE THE SAFETY AND EFFICACY OF CAMPATH-1H AS AN INDUCTION AGENT IN COMBIANTION IWTH TACROLIMUS MONOTHERAPY COMPARED TO SHORT-COURSE ATG-INDUCTION IN COMBINATION WITH TACROLIMUS; MYCOPHENOLATE MOFETIL AND SHORT-TERM STEROIDS APPLICATION IN DE NOVO SPK TRANSPLANTED DIABETIC PATIENTS - SIMPATICOType 1-diabetic patients undergoing simultaneous pancreas-kidney (SPK) allograft transplantation.
EUCTR2006-000845-21-ATniversity Hospital Innsbruck60
进行中(未招募)
1 期
AN OPEN-LABEL; RANDOMIZED; PROSPECTIVE STUDY TO INVESTIGATE THE SAFETY AND EFFICACY OF CAMPATH-1H AS AN INDUCTION AGENT IN COMBIANTION IWTH TACROLIMUS MONOTHERAPY COMPARED TO SHORT-COURSE ATG-INDUCTION IN COMBINATION WITH TACROLIMUS; MYCOPHENOLATE MOFETIL AND SHORT-TERM STEROIDS APPLICATION IN DE NOVO SPK TRANSPLANTED DIABETIC PATIENTS - SIMPATICOType 1-diabetic patients undergoing simultaneous pancreas-kidney (SPK) allograft transplantation.
EUCTR2006-000845-21-DEniversity Hospital Innsbruck20
已完成
不适用
OPEN-LABEL, RANDOMIZED, CROSSOVER STUDY TO ASSESS THE DOSE-DEPENDENT EFFECT OF RIFAMPICIN ON THE PHARMACOKINETICS OF ENDOGENOUS BIOMARKERS AND PROBE DRUGS FOR ASSESSMENT OF DRUG-DRUG INTERACTIONS MEDIATED BY OATP1BHealthy volunteers (Japanese male)
JPRN-UMIN000033695P-One Clinic,Keikokai Medical Corp.8
进行中(未招募)
4 期
A comparison of oral Terbinafine and Itraconazole in stubborn Tinea infections
CTRI/2019/07/019964Dr Vasudha Sharma